Skip to main content

Table 1 List of the alleles and sequence type, origin of the sample, antibiotic pattern and number of patient for each isolate

From: Genetic diversity of clinical Pseudomonas aeruginosa isolates in a public hospital in Spain

Isolates Patient Sample origina STs acsA aroE guaA mutL nuoD ppsA trpE Antibiotic patternb
PaC1 1 W ST-1138* 5 3 79 5 1 7 47 XDR
PaC49 1 RS ST-1191* 45 148* 15 35 53 106* 3 MDR
PaC51 1 RS ST-1147* 17 3 5 3 1 6 26 non-MDR
PaC52 1 W ST-1138* 5 3 79 5 1 7 47 XDR
PaC2 2 W ST-175 28 22 5 3 3 14 19 XDR
PaC3 3 R ST-235 38 11 3 13 1 2 4 non-MDR
PaC4 4 R ST-800 17 22 11 3 3 15 3 non-MDR
PaC5 5 W ST-108 39 5 20 5 1 6 31 XDR
PaC7 6 R New-1 28 5 36 - 3 13 7 MDR
PaC16 6 R New-2 28 5 20 - 3 13 7 MDR
PaC9 7 U ST-274 23 5 11 7 1 12 7 XDR
PaC10 8 U ST-1139* 28 22 20 3 3 14 19 XDR
PaC19 8 U ST-175 28 22 5 3 3 14 19 XDR
PaC32 8 RS ST-175 28 22 5 3 3 14 19 XDR
PaC40 8 R ST-175 28 22 5 3 3 14 19 XDR
PaC11 9 U ST-235 38 11 3 13 1 2 4 XDR
PaC24 9 U ST-235 38 11 3 13 1 2 4 XDR
PaC12 10 R ST-1140* 38 11 20 13 1 2 4 XDR
PaC14 11 R ST-1141* 113 4 5 67 1 17 26 non-MDR
PaC15 12 R ST-1142* 35 11 112 16 1 6 42 MDR
PaC17 13 R ST-1186* 39 5 20 59* 1 20 15 non-MDR
PaC18a 14 U ST-1143* 8 5 9 3 1 4 9 non-MDR
PaC18b 14 U ST-1143* 8 5 9 3 1 4 9 non-MDR
PaC20 15 U ST-1144* 39 10 1 3 4 6 7 non-MDR
PaC21 16 R ST-175 28 22 5 3 3 14 19 XDR
PaC23 17 U ST-1187* 35 22 5 3 1 104* 4 non-MDR
PaC25a 18 U ST-207 47 4 5 33 1 6 40 non-MDR
PaC25b 18 U ST-207 47 4 5 33 1 6 40 non-MDR
PaC26 19 R ST-235 38 11 3 13 1 2 4 XDR
PaC27 20 R ST-274 23 5 11 7 1 12 7 non-MDR
PaC28 21 U ST-1188* 69* 147* 5 11 2 15 2 MDR
PaC29 22 R ST-1145* 15 5 1 1 1 12 1 non-MDR
PaC30 23 PS ST-244 17 5 12 3 14 4 7 non-MDR
PaC31 24 U ST-499 11 5 7 27 2 7 33 MDR
PaC33 25 R ST-175 28 22 5 3 3 14 19 XDR
PaC34 26 R ST-179 36 27 28 3 4 13 7 MDR
PaC35 27 U ST-235 38 11 3 13 1 2 4 MDR
PaC36a 28 R ST-175 28 22 5 3 3 14 19 XDR
PaC36b 28 R ST-175 28 22 5 3 3 14 19 MDR
PaC37 29 B ST-175 28 22 5 3 3 14 19 XDR
PaC38 29 B ST-175 28 22 5 3 3 14 19 XDR
PaC39 30 U ST-508 15 5 11 3 2 4 3 non-MDR
PaC41 31 U ST-1189* 72* 5 11 72 3 105* 3 non-MDR
PaC42 32 W ST-253 4 4 16 12 1 6 3 MDR
PaC56 32 B ST-253 4 4 16 12 1 6 3 MDR
PaC43 33 R ST-235 38 11 3 13 1 2 4 XDR
PaC44 34 U ST-316 13 8 9 3 1 6 9 non-MDR
PaC45 35 U ST-175 28 22 5 3 3 14 19 XDR
PaC46 36 R ST-1190* 45 148* 15 35 53 106* 19 MDR
PaC47 37 R ST-175 28 22 5 3 3 14 19 XDR
PaC48 38 R ST-253 4 4 16 12 1 6 3 non-MDR
PaC54 38 R ST-253 4 4 16 12 1 6 3 non-MDR
PaC50 39 US ST-1146* 5 11 57 33 1 6 3 non-MDR
PaC53 40 U ST-1148* 16 5 12 3 2 1 18 non-MDR
PaC55 41 R ST-179 36 27 28 3 4 13 7 non-MDR
PaC57 42 R ST-1149* 18 11 57 5 1 20 26 non-MDR
  1. Asterisk mark (*) indicates the new alleles, new alleles combinations, and new sequence types described in this study. -, gene not amplified/sequenced.
  2. aSample origin: blood (B), wound (W), urine (U), respiratory (R), rectal smear (RS), urethral smear (US), prepuce smear (PS).
  3. bThe isolates were classified according to the resistance pattern, as multidrug-resistant (MDR, non-susceptible to ≥1 agent in ≥3 antibiotic categories), extensively drug-resistant (XDR, non-susceptible to ≥ 1 agent in all but ≤2 antibiotic categories) and non-multidrug resistant (non-MDR).